نتائج البحث - "Stephan Kanzler"

1

دورية أكاديمية

Integrated Analysis of the RASH Study with the Use of the 'Burden of Therapy' (BOTh®TM) Methodology—A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer

المصدر: Current Oncology, Vol 30, Iss 6, Pp 5828-5834 (2023)

مصطلحات موضوعية: burden of therapy, erlotinib, FOLFIRINOX, gemcitabine, pancreatic cancer, quality of life, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/1718-7729/30/6/436Test; https://doaj.org/toc/1198-0052Test; https://doaj.org/toc/1718-7729Test

الوصول الحر: https://doaj.org/article/d4ab867951864e49ad0edeb7b333eb01Test

View record in DOAJ

النص الكامل

2

دورية أكاديمية

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

المؤلفون: Martin F. Sprinzl, Sonia M. Wytopil, Anja Dahmen, Stephan Kanzler, Peter R. Galle, Markus Moehler M.D., Ph.D.

المصدر: Clinical Medicine Insights: Oncology, Vol 2 (2008)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1179-5549Test

الوصول الحر: https://doaj.org/article/f56db1628c90405d9a806ccf55112de9Test

View record in DOAJ

3

Predictive Value of Preoperative Endoscopic Ultrasound (EUS) After Neoadjuvant Chemotherapy in Locally Advanced Esophagogastric Cancer – Data From a Randomized German Phase II Trial

المؤلفون: Visvakanth Sivanathan, Christoph Utz, Thomas Thomaidis, Friedrich Förster, Michael Stahl, Florian Lordick, Stefan Ibach, Stephan Kanzler, Andreas Adler, Stefan Paul Mönig, Carl C. Schimanski, Andre Ignee, Christoph F. Dietrich, Peter R. Galle, Markus Moehler

المصدر: Ultraschall in der Medizin - European Journal of Ultrasound. 43:514-521

مصطلحات موضوعية: Radiology, Nuclear Medicine and imaging, digestive system diseases

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6712da086bffa9d5729e9b83e57c95ecTest
https://doi.org/10.1055/a-1593-4401Test

4

Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial

المؤلفون: Michael Dreher, Christian Grohè, Niels-Ulrik Hartmann, Stephan Kanzler, Karin Kraft, Christoph Sarrazin, Michael Doll, Jens Spiesshöfer, Stephan Steiner, Jochen Wöhrle, Julia Seeger, Kristina Röschmann-Doose, Jörn Thomsen, Thomas Wittig, Nikolaus Marx, Stephan Eisenmann

المصدر: Advances in therapy 39(6), 3011-3018 (2022). doi:10.1007/s12325-022-02135-z

مصطلحات موضوعية: Dyspnea, Treatment Outcome, Double-Blind Method, SARS-CoV-2, COVID-19, Humans, Pharmacology (medical), ddc:610, General Medicine, Prospective Studies, Respiratory Insufficiency

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38c5b61cb4f1a2cb5e4321f67ecaeb5Test
https://pubmed.ncbi.nlm.nih.gov/35419650Test

5

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)

المصدر: Journal of Cancer Research and Clinical Oncology

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Organoplatinum Compounds, Colorectal cancer, Original Article – Clinical Oncology, Leucovorin, Disease, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Disease dynamics, FOLFOXIRI, Metastatic colorectal cancer, Panitumumab, General Medicine, Middle Aged, Primary tumor, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Female, Fluorouracil, Colorectal Neoplasms, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Randomization, BRAF, Combination chemotherapy, 03 medical and health sciences, Internal medicine, medicine, Humans, Aged, business.industry, Wild type, medicine.disease, Early tumor shrinkage, 030104 developmental biology, Tumor progression, Mutation, Primary tumor site, ras Proteins, Camptothecin, business, Depth of response

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6834639b3ec002c9bc256673519e750Test
https://doi.org/10.1007/s00432-020-03257-zTest

6

FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109)

المؤلفون: Uwe M. Martens, Swen Wessendorf, Heinemann, Petra Buechner-Steudel, J. Greeve, Axel Florschütz, Thomas J. Ettrich, Andrea Tannapfel, Anke Reinacher-Schick, Thomas Seufferlein, Michael Geissler, Swantje Held, Jens Atzpodien, Jens Ricke, Max Seidensticker, Jorge Riera-Knorrenschild, Stephan Kanzler, Dominik Paul Modest, Dominik Nörenberg

المصدر: Journal of Clinical Oncology. 37:3401-3411

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b2c87cf9f825e3641aa69916765fb581Test
https://doi.org/10.1200/jco.19.01340Test

7

AcceleRET Lung: A phase 3 study of first-line pralsetinib in patients with RET fusion–positive advanced/metastatic NSCLC

المصدر: Journal of Clinical Oncology. 40:TPS9159-TPS9159

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3fe20b867f0c13f833adecf9ff4cf77cTest
https://doi.org/10.1200/jco.2022.40.16_suppl.tps9159Test

8

Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' method

المصدر: European journal of cancer (Oxford, England : 1990). 146

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, endocrine system diseases, medicine.medical_treatment, Afatinib, Deoxycytidine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Pancreatic cancer, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, Adverse effect, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, business.industry, Hazard ratio, Middle Aged, medicine.disease, Prognosis, Rash, Gemcitabine, Pancreatic Neoplasms, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, medicine.symptom, business, medicine.drug, Carcinoma, Pancreatic Ductal, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::626b1457beccaa55a826dd0f85764209Test
https://pubmed.ncbi.nlm.nih.gov/33588150Test

9

FOLFOXIRI Plus Panitumumab As First-Line Treatment of

المؤلفون: Dominik P, Modest, Uwe M, Martens, Jorge, Riera-Knorrenschild, Jobst, Greeve, Axel, Florschütz, Swen, Wessendorf, Thomas, Ettrich, Stephan, Kanzler, Dominik, Nörenberg, Jens, Ricke, Max, Seidensticker, Swantje, Held, Petra, Buechner-Steudel, Jens, Atzpodien, Volker, Heinemann, Thomas, Seufferlein, Andrea, Tannapfel, Anke C, Reinacher-Schick, Michael, Geissler

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37(35)

مصطلحات موضوعية: Adult, Male, Panitumumab, Liver Neoplasms, Leucovorin, Middle Aged, Irinotecan, Prognosis, Bevacizumab, Oxaliplatin, Survival Rate, Case-Control Studies, Antineoplastic Combined Chemotherapy Protocols, Mutation, ras Proteins, Humans, Female, Colorectal Neoplasms, Aged, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::6763a0adf53702aee67eb7ce50c868c8Test
https://pubmed.ncbi.nlm.nih.gov/31609637Test

10

Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’

المؤلفون: Jens T. Siveke, Swantje Held, Anke Reinacher-Schick, Thomas J. Ettrich, Miriam Fuchs, Stefan Boeck, L. Fischer von Weikersthal, J. Freiberg-Richter, Stephan Kruger, Stephan Kanzler, Karel Caca, Markus M. Lerch, Volker Heinemann, M. Schenk, Volker Kunzmann, Michael Haas, Frank Kullmann, Christoph B. Westphalen

المصدر: European Journal of Cancer. 94:95-103

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, FOLFIRINOX, Medizin, Leucovorin, Phases of clinical research, Kaplan-Meier Estimate, Irinotecan, Deoxycytidine, Erlotinib Hydrochloride, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Pancreatic cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Organometallic Compounds, medicine, Humans, Prospective Studies, Survival rate, Aged, Proportional Hazards Models, business.industry, Middle Aged, medicine.disease, Gemcitabine, Rash, Progression-Free Survival, Oxaliplatin, Pancreatic Neoplasms, Drug Combinations, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Drug Eruptions, Fluorouracil, Folfirinox Regimen, Erlotinib, medicine.symptom, business, Carcinoma, Pancreatic Ductal, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1565900dcef3ff210b7562bd6ad928bcTest
https://doi.org/10.1016/j.ejca.2018.02.008Test

تنقيح النتائج